Mechanical Ventilation of the Neonate

Published on 12/06/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 6293 times

16 Mechanical Ventilation of the Neonate

Note 1: This book is written to cover every item listed as testable on all Entry Level Examination (ELE), Written Registry Examination (WRE), and Clinical Simulation Examination (CSE).

The listed code for each item is taken from the National Board for Respiratory Care’s (NBRC) Summary Content Outline for CRT (Certified Respiratory Therapist) and Written RRT (Registered Respiratory Therapist) Examinations (http://evolve.elsevier.com/Sills/resptherapist/). For example, if an item is testable on both the ELE and WRE, it will simply be shown as (Code: …). If an item is only testable on the ELE, it will be shown as (ELE code: …). If an item is only testable on the WRE, it will be shown as (WRE code: …).

Following each item’s code will be the difficulty level of the questions on that item on the ELE and WRE. (See the Introduction for a full explanation of the three question difficulty levels.) Recall [R] level questions typically expect the exam taker to recall factual information. Application [Ap] level questions are harder because the exam taker may have to apply factual information to a clinical situation. Analysis [An] level questions are the most challenging because the exam taker may have to use critical thinking to evaluate patient data to make a clinical decision.

Note 2: A review of the most recent Entry Level Examinations (ELE) has shown an average of one question (out of 140), or <1% of the exam, will cover continuous positive airway pressure (CPAP) or mechanical ventilation of the neonate. A review of the most recent Written Registry Examinations (WRE) has shown an average of two questions (out of 100), or 1% of the exam, will cover continuous positive airway pressure (CPAP) or mechanical ventilation of the neonate. Of the 10 tested scenarios of the Clinical Simulation Examination, expect one neonatal patient and one pediatric patient. CPAP or mechanical ventilation may be involved in both situations. Be sure to review neonatal and pediatric assessment items in Chapter 1.

MODULE A

1. Initiate and adjust an elevated baseline pressure: continuous positive airway pressure (CPAP) breathing (Code: IIID2d) [Difficulty: ELE: R, Ap; WRE: An]

a. Physiologic effects

Continuous positive airway pressure (CPAP) and positive end-expiratory pressure (PEEP) increase the patient’s functional residual capacity (FRC). In neonates, the most common cause of a decreased FRC is infant respiratory distress syndrome (RDS). This condition is caused by the lack of surfactant in the lungs of the premature neonate. The neonate with RDS has relatively airless lungs that are prone to atelectasis. This results in hypoxemia. In addition, each tidal volume breath requires a greater than normal inspiratory effort (Figure 16-1). The restoration of FRC in the neonate increases its Pao2, decreases the percentage of shunt, narrows the alveolar to arterial difference in oxygen, and reduces its work of tidal volume breathing. CPAP must be used with caution in neonates with persistent pulmonary hypertension (PPHN) of the newborn. An excessive amount of pressure in the alveoli compresses the capillary bed. This decreases pulmonary blood flow, which in turn increases blood flow through the patent ductus arteriosus and worsens the problem.

b. Indications, contraindications, and hazards

CPAP is indicated for any condition that results in an unacceptably low Pao2 secondary to a decreased FRC. Some neonates respond so well to CPAP that mechanical ventilation is not needed. In addition, CPAP has been used to keep open the airways of infants with tracheal malacia or other conditions in which the airways collapse abnormally. In general, contraindications include any CPAP-related condition that results in a worsening of the patient’s original status. Some neonates cannot tolerate CPAP and progressively hypoventilate as the pressure level is increased. Clinical judgment is needed to decide how high the PaCO2 should be allowed to rise before discontinuing the CPAP and beginning mechanical ventilation. In general, the PaCO2 should not be greater than 50 torr as long as the pH is at least 7.25. An absolute contraindication is apnea resulting in hypoxemia and hypotension. These infants should be mechanically ventilated. Box 16-1 gives a complete listing of indications, contraindications, and hazards.

BOX 16-1 Indications, Contraindications, and Hazards of CPAP Therapy

c. Initiation

Before starting CPAP, a set of baseline arterial blood gases should be taken. Transcutaneous oxygen monitoring or pulse oximetry may be substituted in some clinical situations if oxygenation is the only parameter that must be measured. The neonate’s vital signs should also be recorded. Assemble the CPAP circuit and pressure device. The decision must be made whether to apply the CPAP above the epiglottis (Figures 16-2 and 16-3) or to intubate the infant and apply the CPAP within the trachea. Nasal CPAP (NCPAP) or nasopharyngeal tube CPAP (NP-CPAP) are both widely used to apply pressure from above the epiglottis. The neonate or infant must have an endotracheal tube placed to apply CPAP within the trachea. Among the factors to be considered are the neonate’s gestational age and weight, the amount of secretions that need to be suctioned, the pulmonary problem, and the likelihood of mechanical ventilation eventually becoming necessary. More mature and larger infants with few secretions and relatively stable pulmonary conditions will most likely have CPAP applied above the epiglottis by nasal prongs or nasopharyngeal tube. In contrast, less mature and smaller infants (less than 1000 to 1200 g) who need suctioning and have relatively unstable pulmonary conditions will probably be intubated. Mechanical ventilation can then be easily started if needed.

image

Figure 16-3 An assembly for supporting nasal CPAP prongs in an infant.

(Modified from advertisement of Stayflex tubing system from Ackrad.) (From Sills JR: Respiratory care registry guide, ed 1, St Louis, 1994, Mosby.)

CPAP is usually started at about 4 to 5 cm water pressure whether the pressure is applied above or below the epiglottis. The inspired oxygen percentage is usually kept at the previously set level. It is important to make only one change at a time so that each adjustment in care can be evaluated for its own effect. For example, if you simultaneously increased the oxygen percentage by 10% and started 5 cm water of CPAP, it would not be known whether the increase in Pao2 was from the additional oxygen, the CPAP, or both. Usually the long-term inspired oxygen is limited to 40% to 50% because of concern of the possibility of pulmonary oxygen toxicity.

e. CPAP adjustment

Blood gases and vital signs must be evaluated at the starting CPAP level. The heart rate, blood pressure, and respiratory rate should be stable or improved. Wait at least 10 minutes after a change in CPAP before getting an arterial blood gases sample. See Table 16-1 for the recommended blood gas limits. In general, the Pao2 should be kept between 60 and 70 torr, PaCO2 less than 50 to 55 torr, and pH at least 7.25. If the Pao2 is too low and the patient’s vital signs are acceptable, the CPAP may be increased in a step of 1 to 2 cm water. The vital signs and blood gases should then be reevaluated. In addition, the neonate’s work of breathing can be indirectly assessed. Improved lung function will be demonstrated by seeing decreased respiratory rate, retractions, expiratory grunting, and nasal flaring. If necessary, the process of adding CPAP and reassessing the patient can be continued. The maximum CPAP level in a neonate is generally held to be 10 cm water; the maximum CPAP level in an infant is generally held to be 15 cm water.

TABLE 16-1 Commonly Recommended Blood Gas Goals for CPAP and Mechanical Ventilator Therapy

  Age of Neonate
  Less Than 72 Hours Greater Than 72 Hours
Pao2 (torr) 60-70 50-70
Ptco2 (torr) Greater than 50,* less than 90* Greater than 40,* less than 90*
Spo2 92%-96% 92-96%
PaCO2 (torr) 35-45 45-55
PtcCO2 (torr) May be used after correlation with PaCO2 as discussed in Chapter 3.
pH 7.25-7.45 7.25-7.45

NOTE: Keep the Pao2 no greater than 80 torr in the premature neonate to reduce the risk of retinopathy of prematurity.

* Ptco2 values may be used after they have been shown to correlate within 15% of the Pao2 from an arterial blood gas.

With CPAP, this value may be increased to 50 to 55 torr as long as the pH is at least 7.25.

Mechanical ventilation is usually indicated if more than these maximum CPAP pressures are needed to correct hypoxemia. Depending on the patient, even levels less than these maximum CPAP pressures may not be well tolerated. The infant may become exhausted from exhaling against the back pressure of the CPAP system. That is seen clinically as decreased chest movement from the smaller tidal volume. The PaCO2 will probably increase. It may be necessary to place the infant on mechanical ventilation to decrease the work of breathing and then add PEEP to maintain the FRC. When nasal prongs or a nasopharyngeal tube are used, CPAP pressures of greater than 8 cm water may cause the infant’s mouth to open. This results in the loss of CPAP. A crying infant also opens its mouth and loses the CPAP. In either case, the CPAP pressure gauge drops to zero or fluctuates below the set pressure.

f. Independently initiate weaning from CPAP (Code: IIIF2i12) [Difficulty: ELE: R, Ap; WRE: An]

As the patient improves, it is necessary to reduce the CPAP level so as not to cause pulmonary barotrauma. The pressure level can be reduced in steps of about 2 cm water. The vital signs and blood gases should be reassessed after each step. The apparatus is usually removed when the CPAP level is down to 2 to 4 cm water. The infant is then placed into an oxyhood at the same oxygen percentage as before or 5% to 15% higher. If the infant has an endotracheal tube that is needed for suctioning or a secure airway, the pressure is usually left at 2 to 4 cm water. After extubation, the infant is placed into an oxyhood as before. Alternatively, the neonate may be weaned to a high flow nasal cannula and then to a traditional, low-flow nasal cannula. See Chapter 6 for more discussion on the high-flow nasal cannula.

If the infant was breathing more than 50% oxygen while on the CPAP, it may be more important to lower the oxygen before decreasing the CPAP level. The following guidelines may prove helpful when deciding whether to first lower the oxygen percentage or the CPAP level:

MODULE B

1. Select a mechanical ventilation

b. Independently change the type of ventilator to be used on the patient (Code: IIIF2i9) [Difficulty: ELE: R, Ap; WRE: An]

Historically, most neonatal patients requiring life sup-port receive time-triggered, pressure-limited, time-cycled mechanical ventilation (TPTV). These ventilators are pneumatically powered with electrical controls and alarm systems. They are used in the IMV mode and feature a continuous flow of gas from which the neonate can breathe spontaneously. TPTV units are pressure limited to prevent an excessive peak airway pressure and can have therapeutic PEEP added. Furthermore, they are capable of reaching the Food and Drug Administration (FDA) limited rate of 150 breaths/min. The majority of neonatal and small pediatric patients can be effectively ventilated on these types of units.

High-frequency ventilation (HFV) with a small tidal volume has been approved by the FDA for use in the rescue of neonates with RDS and a bronchopulmonary fistula or pulmonary interstitial emphysema (PIE) who fail under conventional TPTV ventilation. HFV has also been used in the short-term support of neonates with a congenital diaphragmatic hernia until corrective surgery can be performed.

Volume-cycled ventilators are commonly used on infants who weigh more than 10 kg (22 lb). The most recent generation of conventional volume-cycled ventilators can be used to deliver a tidal volume as small as 2 to 3 mL. They often have chest wall sensor systems that note movement and match that breathing effort with a machine delivered breath. Volume-oriented ventilation can also be performed with a neonatal TPTV-type ventilator if the patient is apneic. This technique is discussed later.

When selecting a ventilator, it is important to choose one that offers the features needed to ventilate the patient. For example, if real-time graphics are needed to evaluate the patient’s response to a ventilator adjustment, the proper unit will be needed. Any selected ventilator must be able to meet the typical tidal volume goal for a neonatal of 4 to 6 mL/Kg or small pediatric patient of 6 to 8 mL/Kg. A patient receiving HFV for an FDA-approved pulmonary problem has a smaller tidal volume goal.

2. Adjust the ventilator settings.

3. Indications for mechanical ventilation

All authors agree that apnea is an absolute indication for mechanical ventilation. A general indication is any condition that causes respiratory failure. This is usually documented by unacceptable arterial blood gases. Box 16-2 lists indications for mechanical ventilation.

Math Review

TIME CONSTANTS OF VENTILATION

Note: This concept has not been directly tested by the NBRC. It is hoped that understanding the concept of time constants as used here and in the later text will help the reader understand lung pathology and why certain ventilator adjustments are made.

It is important in any patient requiring mechanical ventilation to consider both the patient’s lung-thoracic compliance and airway resistance when setting inspiratory and expiratory times. This is especially important in neonates because, in comparison with adults, they are less compliant and have greater resistance. In addition, neonates are usually ventilated at faster rates. As a review, the respective lung-thoracic compliances (CLT) and airway resistances (RAW) of normal adults and infants are shown here:

The placement of an endotracheal tube to facilitate mechanical ventilation results in a total pulmonary resistance ranging from 50 to 150 cm water/L/sec. The time constant of ventilation (Tc or time constant of the respiratory system TRS) is calculated as the product of compliance and resistance:

image

For example, using these values for a spontaneously breathing normal neonate, its time constant is calculated as

image

Although technically impractical to measure the time constant of ventilation at the bedside, the concept is important because it relates to two important clinical considerations during mechanical ventilation. First, it relates to the pressure that develops at the alveolar level as the tidal volume is delivered. For each time constant, progressively more of the peak inspiratory pressure (PIP) is applied within the alveoli (Figure 16-4). As can be seen, at three time constants, 95% of the PIP is applied to the alveoli. At five time constants, virtually the entire PIP is applied at the alveolar level. Second, the time constant relates to how rapidly the lung recoils to baseline (FRC) during an exhalation. As shown in Figure 16-4, it takes three time constants to exhale 95% and five time constants to completely exhale.

The clinical significance of this relates directly to the pulmonary condition of the patient. Infants with stiff lungs and normal resistance, as found in RDS, have a short time constant. Alveolar pressure quickly increases to match the peak inspiratory pressure. The lungs then rapidly recoil during exhalation so that there is little chance of air trapping. Infants with normal compliance and increased resistance, as found in meconium aspiration, have a long time constant. It takes a relatively long time for the alveolar pressure to reach the PIP. Also, a relatively long time is needed for the exhalation to be complete. For this reason, these infants are at risk for air trapping and auto-PEEP.

4. Initiation and adjustments based on the patient’s condition

a. Patients with normal cardiopulmonary function

Patients with normal cardiopulmonary function may need mechanical ventilation because of apnea from anesthesia, paralysis, or a neurologic condition. The initial TPTV ventilator parameters for this type of patient are listed in Box 16-3. Once mechanical ventilation is established, it is important to evaluate the patient’s blood gases, vital signs, breath sounds, and any other pertinent clinical information before changing any ventilator parameters.

As the patient recovers and begins to breathe spontaneously, it will probably be necessary to reduce the ventilator-delivered minute volume. This encourages the child to breathe more because the final goal is to completely wean and extubate the patient. The most accepted way to reduce the ventilator-delivered minute volume is to reduce the ventilator rate. A reduction of about 10% is a good starting place but must be tailored to meet the patient’s needs. The tidal volume is maintained as originally set. Obtain a set of blood gases in 10 to 20 minutes (or follow the transcutaneous or pulse oximetry values), and check the patient’s vital signs to see how well the adjustment is tolerated.

If the blood gases show an elevated PaCO2, the ventilator-delivered minute volume must be raised. Do this by increasing either the alveolar ventilation or respiratory rate. Alveolar ventilation can be increased by increasing either the inspiratory flow or the pressure limit (if it has been reached) to increase the tidal volume. The ventilator rate may be increased if the flow and pressure limit cannot be increased. An increase of about 10% is a good starting place but must be tailored to meet the patient’s needs. As before, blood gases and vital signs should be monitored after every change to see if the increase is well tolerated and accomplishing what was intended.

If the blood gases show that the PaCO2 is lower than desired, the ventilator-delivered minute volume must be decreased. The first parameter to adjust is usually the rate. Try decreasing the rate by about 10% and check another set of blood gas values. If other parameters need to be reduced, try decreasing the peak inspiratory pressure, inspiratory flow, or inspiratory time about 10% to decrease the tidal volume. Again, check the blood gas values after every adjustment.

If the blood gases show that the Pao2 is higher or lower than necessary, the oxygen percentage must be adjusted. An increase or decrease of about 5% is a good starting place but must be adjusted as needed. If the patient does not respond to the increased oxygen as expected, the patient should be reevaluated. It may be necessary to reclassify him or her into one of the following categories.

Math Review

CALCULATION OF ESTIMATED TIDAL VOLUME DURING TPTV MECHANICAL VENTILATION

The NBRC examination content outline does not specifically list estimated tidal volume calculations. However, the information may be useful in understanding concepts presented later in the text.

If the neonatal patient receiving TPTV is apneic and neither assisting nor fighting against the ventilator-delivered breath, it is possible to calculate an approximate tidal volume. This is referred to as volume-oriented ventilation. The following formula is used:

image

In which

TI = inspiratory time

(It is important that either the pressure limit is not reached or the pressure limit is reached at the same time inspiratory time is completed. If the pressure limit is reached before the inspiratory time limit is reached, part of the inspiratory time is spent as an inflation hold, and no additional tidal volume is delivered.)

image = inspiratory flow rate on the ventilator in mL/sec

Vc = volume compressed in the circuit and ventilator

(This is found by multiplying the peak inspiratory pressure by the manufacturer’s stated compliance factors for the circuit and ventilator.)

For example, estimate the delivered tidal volume for an apneic 5 kg infant. The ventilator parameters are inspiratory flow of 5.5 l/min, frequency of 20/min, I : E ratio of 1 : 3, inspiratory time of 0.75 seconds, and expiratory time of 2.25 seconds. Peak inspiratory pressure (PIP) is 15 cm water. The internal compliance of the ventilator is 0.4 mL/cm water, and the circuit compliance factor is 1.6 mL/cm water.

image

In which:

Therefore,

image

It must be emphasized that this is only a calculated tidal volume. Leaks in the system, a decrease in the patient’s compliance, or an increase in the patient’s resistance decreases the true tidal volume. Conversely, an increase in the patient’s compliance or a decrease in the patient’s resistance increases the true tidal volume. Also, if the pressure limit is reached before the inspiratory time is completed, less volume than expected will be delivered. This is because part of the inspiratory time is spent as an inflation hold and no additional tidal volume is delivered (Figure 16-5). Finally, the infant must be completely passive during the delivery of the breath.

b. Patients with decreased lung compliance and normal airway resistance such as infant respiratory distress syndrome (RDS)

Although RDS in infants weighing less than 1000 g is the most common cause of decreased lung compliance with normal airway resistance, stiff lungs are also found in patients with other lung conditions such as pneumonia and pulmonary edema (Figure 16-6). The greatest challenge presented in the care of these infants is to oxygenate them without causing oxygen toxicity or pulmonary barotrauma. Common recommendations for the initial ventilator settings are listed in Box 16-4. As discussed earlier, blood gases, vital signs, and so forth must be monitored after the infant is placed on the ventilator. Any further adjustments can then be determined and evaluated by another set of blood gases and vital signs.

The issue of time constants of ventilation helps to better explain the various options available for adjusting the ventilator. As presented earlier, the time constant of ventilation (Tc or time constant of the respiratory system TRS) is calculated as the product of compliance and resistance. For example, using the following values for a mechanically ventilated neonate with RDS, its time constant is calculated as

image

Neonates with RDS have a relatively short time constant; therefore the tidal volume and ventilating pressure are delivered rather quickly to the lungs. However, because the lungs are so stiff, there is usually no problem with the tidal volume being fully exhaled as long as five time constants are allowed. An expiratory time of at least 0.5 seconds is usually set initially. The various options available for increasing oxygenation are discussed on the following pages.

1. Administer oxygen

c. Independently modify mechanical ventilation to enhance oxygenation (Code: IIIF2i2) [Difficulty: ELE: R, Ap; WRE: An]. Up to 100% oxygen can be given to the neonate in the short term. Hypoxemia cannot be tolerated and supplemental oxygen is usually the best way to correct it. See Chapter 15 for equations that can be used to predict the oxygen percentage change needed to correct the patient’s hypoxemia. Although hypoxemia cannot be tolerated, there are several limiting factors. First, it is commonly held that giving more than 50% oxygen for more than 48 to 72 hours increases the risk of pulmonary oxygen toxicity. Second, if more than 80% oxygen is given, some poorly ventilated alveoli will have all of the oxygen absorbed from them, leading to denitrogenation absorption atelectasis. Third, keep the neonate’s Pao2 below 80 torr to minimize the risk of retinopathy of prematurity (ROM). Fourth, if the hypoxemia is caused by a decreased FRC because of the lack of surfactant and small lung volumes, increasing the oxygen will not markedly increase the Pao2. Other solutions, such as adding PEEP, altering the I : E ratio to lengthen the inspiratory time, and giving surfactant must be used. These will be discussed later.

2. Increased inspiratory flow

Increasing the tidal volume should result in an increased Pao2 and is likely to reduce the PaCO2. If the pressure limit is reached, the delivered tidal volume is held in the lungs for the duration of the inspiratory time. This acts as an inflation hold and should also increase the Pao2. The mean airway pressure is raised by holding the tidal volume in the lungs. (See Figure 16-7 for the pressure waveforms seen during low-flow and high-flow conditions.) Under high-flow conditions, the pressure waveform takes on a characteristic square shape (square wave) because the pressure limit is reached. This pattern of ventilation is currently widely used with these types of patients.

3. Increased inspiratory time leading to inverse ratio ventilation

As with increasing the flow, increasing the inspiratory time increases the tidal volume until the pressure limit is reached. If the pressure limit is reached, any increased inspiratory time acts as inflation hold. This also raises the mean airway pressure and should result in an increased Pao2. (See Figure 16-5 for the pressure waveform change as the inspiratory time is increased.)

Some authors have advocated an increased inspiratory time as an important way to improve oxygenation. This has led to the use of inverse I : E ratios of up to 3 : 1 (.33) or 4 : 1 (.25) to produce an adequate Pao2. The inspiratory time should be increased in small time increments and followed in 10 to 20 minutes with a blood gas to determine if the desired improvement in oxygenation was achieved. Inspiratory time is increased only as long as necessary to result in a satisfactory Pao2. Great care must be taken to adjust expiratory time, respiratory rate, or both when a prolonged inspiratory time is used. Obviously, expiratory time must be reduced to keep the same rate as the inspiratory time is increased, or the rate must be reduced as the inspiratory time is increased if the expiratory time cannot be reduced. Care must be taken to ensure that the tidal volume is fully exhaled to avoid auto-PEEP.

As the neonate’s lung compliance improves, the inspiratory time must be decreased for two reasons. First, the alveolar pressure is more readily transmitted throughout the lungs and may decrease venous return to the heart. That results in a decreased cardiac output. Second, the more normal lungs are more prone to barotrauma or volutrauma. The inspiratory time should be decreased in small time increments and followed with a set of blood gases to be sure that the neonate is not hypoxemic.

4. Initiate and adjust an elevated baseline pressure: positive end-expiratory pressure (PEEP) (Code: IIID2d) [Difficulty: ELE: R, Ap; WRE: An]

Positive end-expiratory pressure (PEEP) increases the patient’s functional residual capacity (FRC) by preventing a complete exhalation to the baseline (atmospheric) pressure. Because PEEP increases the FRC, it is more effective at increasing the Pao2 than increasing the tidal volume, inflation hold, or an inverse I : E ratio. See Table 16-1 for the recommended guidelines for arterial blood gas values in neonates. If the patient needs more than 50% oxygen to keep the desired Pao2, PEEP should be started; unless there is a contraindication to its use. Often, the proper level of therapeutic PEEP can result in an acceptable Pao2 with no more than 50% oxygen being inhaled.

As discussed in regard to CPAP therapy, PEEP is usually started out at 4 to 5 cm water. A blood gas is then checked and, if necessary, more PEEP is added in 1 to 2 cm water increments. It is rare for more than 7 cm of PEEP to be needed. Another blood gas should be checked for Pao2 after every addition of pressure. PEEP has the greatest impact on raising the mean airway pressure of all the options presented here. For that reason, excessive PEEP may cause a decreased venous return to the heart and decreased cardiac output. It also may cause barotrauma resulting in pulmonary interstitial emphysema (PIE), pneumothorax, or pneumomediastinum. Care must be taken to carefully evaluate the patient after each increase in PEEP. Watch for a sudden deterioration in the patient’s condition as a sign of a pulmonary air leak. As the patient’s Pao2 improves, the PEEP level should be reduced in steps of about 1 to 2 cm water. As always, recheck the blood gases with each adjustment.

7. Initiate and select appropriate settings for high-frequency ventilation (HFV) (Code: IIID4) [Difficulty: ELE: R, Ap; WRE: An]

High-frequency ventilation (HFV) involves the use of a ventilator respiratory rate that is much greater than commonly needed. The FDA defines HFV as a rate of more than 150/min. Because of this FDA definition of HFV, conventional neonatal TPTV ventilators are not considered high-frequency ventilators. Several manufacturers have developed ventilators capable of rates significantly greater than 150/min. One of these must be used when HFV is indicated. The FDA has also set some guidelines for the appropriate use of HFV. See Box 16-5 for the clinical indications for HFV. The most commonly encountered problem is with a premature neonate with infant respiratory distress syndrome (RDS), a homogenous lung disease causing low compliance. If the RDS patient is failing despite optimal conventional mechanical ventilation and has a mean airway pressure of greater than 15 cm water, high-frequency ventilation is indicated.

Despite the FDA guidelines, many respiratory therapists consider a rate of greater than 40/min on a neonatal patient to be HFV. When a conventional TPTV ventilator is used to deliver a respiratory rate of up to 150/min, the term high-frequency positive pressure ventilation (HFPPV) is used. Experience has shown that many RDS infants can be successfully managed with conventional TPTV ventilator set to deliver a small tidal volume at a rate between 40 and 150/min. However, when these methods fail, true HFV is needed.

Ventilator manufacturers have developed two different technologies for delivering FDA-defined HFV. The first is called high-frequency jet ventilation (HFJV). With HFJV, small jets of gas are directed down the patient’s endotracheal tube. These gas jets entrain additional gas into the tube. The two combined volumes of gas make up the patient’s tidal volume. The patient exhales passively because of normal lung recoil. The second method is called high-frequency oscillation (HFO) or high-frequency oscillatory ventilation (HFOV). With HFO, a pumping device (piston, diaphragm, or sound speaker) actively pushes a small tidal volume into the patient from a continuous flow of gas (called bias flow) passing through the circuit and by the endotracheal tube. HFO technology can deliver very high rates because the patient actively exhales the delivered tidal volume. This active exhalation is created by the back stroke of the pumping device that pulls the tidal volume out of the patient’s airways and lungs. See Table 16-2 for a comparison of HFV methods and characteristics.

Initial HFV settings depend on the patient’s diagnosis, clinical situation, current conventional ventilator settings, and the type of high-frequency ventilator to be used. Generally speaking, the initial HFV settings include a tidal volume large enough to see chest movement and a continuation of the patient’s original mean airway pressure, PEEP level, and oxygen percentage. The I : E ratio should be set at 1 : 2 and the high-frequency rate should be between 10 and 15 Hertz (Hz) depending on the infant’s body weight. (A Hz is defined as 1 respiratory cycle/sec; 60 respiratory cycles/min. For example, a rate of 600/min is 10/sec or 10 Hz.) After the patient is stabilized on HFV, arterial blood gases should be drawn and analyzed, vital signs assessed, and a chest radiograph obtained. In a patient without a pulmonary air leak, a chest radiograph finding of lung expansion to T8 to T9 on the right hemidiaphragm, without intercostal bulging, is believed to show the best lung volume. Once established, the HFV rate is seldom changed. Adjustments in tidal volume are made by increasing or decreasing what is referred to as either drive pressure (with HFJV) or amplitude (with HFO). Increasing drive pressure/amplitude increases the tidal volume and decreases the carbon dioxide level. The patient’s oxygenation should also improve as the mean airway pressure is increased. Decreasing drive pressure/amplitude decreases the tidal volume and increases the carbon dioxide level. If the patient’s oxygenation should decrease too much, additional therapeutic PEEP may be needed. See Table 15-1 for high-frequency ventilation guidelines with infant and adult patients. See Figure 16-9 for a protocol on initiation and adjustment of HFO. Figure 16-10 shows a protocol for weaning from HFO.

image

Figure 16-9 Optimum lung volume HFOV strategy flowchart.

(From Minton S, Gerstmann D, Stoddard R: Cardiopul Rev, Yorba Linda, Calif, 1995, Sensormedics Corp. PN 770118-001.)

image

Figure 16-10 HFOV flowchart for weaning from optimum lung volume strategy.

(From Minton S, Gerstmann D, Stoddard R: Cardiopul Rev, Yorba Linda, Calif, 1995, Sensormedics Corp. PN 770118-001.)

8. Recommend the instillation of exogenous surfactant (Code: IIIG4j) [Difficulty: ELE: R, Ap; WRE: An]

The primary problem with a premature neonate with RDS is the lack of surfactant, a phospholipid, to reduce the surface tension in the alveoli. In 1991 the FDA approved the use of exogenous surfactant that can be directly instilled into the lungs of RDS neonates. Exosurf Neonatal (a synthetic product), Survanta and Infasurf (both bovine lung extract), and Curosurf (a pig lung extract) have been successfully used clinically. These drugs have proven very beneficial to premature neonates with inadequate natural surfactant. After the drug is administered, the patient’s lung compliance improves dramatically. When this improvement occurs, be prepared to rapidly reduce the ventilator-delivered oxygen percentage, rate, pressure limit, and PEEP. The PIP will need to be reduced to keep the same tidal volume. Failure to reduce PIP and PEEP could result in too large a tidal volume and functional residual capacity that could cause pulmonary barotrauma.

Each of the options discussed in this section has its advocates; however, it seems logical that the best possible care would come from the proper application of each option when it is best suited to the patient’s condition. To that end, Chatburn, Waldemar, and Lough (1983) have developed a rather comprehensive approach to the adjustment of the various ventilator parameters to optimize the care of the RDS infant. They use the initial and subsequent blood gas results to direct the various ventilator changes that have been discussed. Because of the complexity of the logic in the algorithm, it is recommended that their articles, listed in the references, be read to fully appreciate its use.

c. Patients with increased airway resistance and normal lung compliance such as meconium aspiration syndrome (MAS)

Although meconium aspiration is a commonly seen cause of increased airway resistance, it is also seen in infants with excessive airway secretions or bronchospasm. These neonates usually have normal lung compliance and their clinical problem is getting enough air into and out of the lungs. The meconium or other obstruction causes uneven airflow and results in hypoxemia, air trapping, auto-PEEP, and an increased risk of barotrauma or volutrauma. Because of these issues, there are two key clinical goals. The first is to minimize turbulence during inspiration by reducing the inspiratory flow rate as much as possible. The second is to give a long enough expiratory time to prevent air trapping. Common recommendations for the ventilator settings are listed in Box 16-6. As discussed earlier, blood gases, vital signs, and so forth must be monitored after the infant is placed on the ventilator. Listen to the breath sounds to detect the end of exhalation and a pause before the start of the next inspiration. This is to ensure that the exhalation has been complete and there is no air trapping that would lead to auto-PEEP. Any further adjustments can then be determined and evaluated by another set of blood gases and vital signs.

Look again at the issue of time constants of ventilation to better understand the various options for adjusting the ventilator. Using the following values for a mechanically ventilated neonate with meconium aspiration, its time constant is calculated as follows:

Tc compliance (.005 L/cm water) × resistance(150 cm water/L/second because the infant is intubated and has an obstructive problem.)

Simplify as follows:

image

(Compare this with a Tc of 0.15 for a normal, spontaneously breathing neonate and a Tc of 0.1 for a ventilated infant with RDS.)

This relatively long time constant means that the tidal volume and peak inspiratory pressure are rather slowly delivered to the alveoli. There is little chance of causing barotrauma or volutrauma from high ventilating pressures; however, it takes a fairly long inspiratory time to deliver an adequate tidal volume. Care must be taken to provide enough expiratory time for the tidal volume to be exhaled completely. Briefly then, the challenge is to deliver an adequate tidal volume to maintain acceptable blood gases at a rate slow enough to prevent air trapping on exhalation.

In general, the inspiratory flow and rate are kept low, inspiratory and expiratory times are kept relatively long, and the I : E ratio should favor a long time for complete exhalation. Furthermore, it is important to frequently suction the airway to remove meconium or secretions. Postural drainage and percussion are also provided to mobilize the secretions so that they can be suctioned out. Usually these procedures and the natural breakdown of meconium result in reduced airway resistance within a few days. Ventilatory support can then be lessened.

d. Patients with persistent pulmonary hypertension of the newborn

Persistent pulmonary hypertension of the newborn (PPHN) is also referred to as persistent pulmonary hypertension (PPH), persistent fetal circulation (PFC), or persistence of the fetal circulation. Infants with PPHN present clinically with an elevated pulmonary artery pressure and a right-to-left shunt through a patent ductus arteriosus (PDA) or the foramen ovale. Therefore, their oxygenation fluctuates greatly. The problem may be seen right after birth or up to 24 hours later. PPHN seems to result from fetal hypoxemia and acidosis. These, in turn, are caused by or associated with maternal drug addiction, infection, preeclampsia, abruptio placenta, postterm gestation, oligohydramnios, and meconium staining or aspiration. The following four tests are done to help confirm the diagnosis:

4. Doppler echocardiography

This procedure can be used to identify an intracardiac shunt through the foramen ovale, shunt through a patent ductus arteriosus, or evidence of increased right ventricular pressure as a sign of pulmonary hypertension.

Any infant who shows signs of PPHN, such as positive results to any of these tests or the need for more than 70% oxygen to prevent hypoxemia, should be considered for hyperventilation therapy. The goal is to reduce pulmonary artery hypertension and thus reduce shunting and improve the Pao2. This is accomplished by hyperventilating the patient to his or her critical PaCO2. Box 16-7 lists common ventilator parameters used to treat persistent pulmonary hypertension. Once the proper ventilator settings are found and the blood gas goals are met, the patient is maintained at this level for 1 or more days. It is often necessary to pharmacologically paralyze the infant with pancuronium bromide (Pavulon) or a similar drug to ensure that the patient’s breathing is synchronized with the ventilator. This is especially important when high ventilator rates are needed. After about 24 hours, the ventilator is adjusted to increase the PaCO2 by 1 to 2 torr. If the peak inspiratory pressure is greater than 45 cm water it should be reduced first. A blood gas is drawn to see if the Pao2 is stable and if the PaCO2 increased the desired small amount. If this first reduction in support is tolerated, it may be slowly followed by further reductions. Each step back from hyperventilation should be small so that the PaCO2 increases only by 1 to 2 mm Hg each time.

As this happens, the patient should be supported in every other way. The medication tolazoline (Priscoline) is a pulmonary vasodilator that has proven to be successful in about one of six neonates with PPHN. Watch for signs of pulmonary barotrauma or bronchopulmonary dysplasia from the high peak pressures and oxygen percentages required with these patients.

5. Inhaled nitric oxide

d. Independently adjust the flow or concentration of nitric oxide (Code: IIIF2e2) [Difficulty: ELE: R, Ap; WRE: An]. Inhaled nitric oxide (iNO) gas has been approved for use as a pulmonary artery vasodilator in neonates with persistent pulmonary hypertension of the neonate (PPHN) and increased pulmonary vascular resistance. Clinical improvement is often seen when a neonate with PPHN or RDS inhales a small amount of nitric oxide. It is important to keep the concentration of iNO as low as possible to achieve this clinical improvement. The upper limit of a therapeutic dose of iNO is less than 20 parts per million (ppm). This is because nitric oxide combines with oxygen to form nitrogen dioxide (NO2). A level of nitrogen dioxide greater than 10 ppm can cause cell damage, hemorrhage, and pulmonary edema leading to death. As the NO2 increases, it causes an increase in the patient’s methemoglobin level. Therefore, the serum level of this nonfunctional form of hemoglobin must also be monitored. Patients who receive iNO are usually also receiving mechanical ventilation. In addition, special iNO measurement and delivery systems are needed and levels of inspired oxygen, nitric oxide, and nitrogen dioxide must be measured. As the patient’s PPHN improves, the level of iNO can be reduced. This is commonly done by reducing the iNO concentration in steps of 50%. For example, if 20 ppm was the original dose on nitric oxide, it would be reduced in steps of 10 ppm, then 5 ppm, and so on until there is 1 ppm or less. The neonate is assessed at each decreasing step to be sure that the pulmonary hypertension does not increase.

A number of medications are used to help optimize the patient’s pulmonary function. Methylxanthines such as aminophylline or caffeine are beneficial as respiratory stimulants. There is further evidence that they help to strengthen the diaphragm and decrease muscle fatigue. The diuretic furosemide (Lasix) has been widely reported to improve lung compliance and airway resistance by decreasing any pulmonary edema fluid. Remember that patients receiving furosemide must be given a potassium-chloride supplement to replace what is lost through the kidneys. Some authors have reported the use of corticosteroids to be helpful in weaning because of increased pulmonary compliance. This possible advantage must be balanced against the known problems associated with the prolonged use of the medication. Finally, a dietary supplement of vitamin E may increase lung healing. It is hoped that the use of surfactant replacement therapy early in the treatment of the RDS neonate will reduce the incidence of BPD.

5. Monitor the mean airway pressure to evaluate the patient’s response to respiratory care (ELE Code: IIIE9) [Difficulty: ELE: R, Ap, An]

Mean airway pressure (Paw) is the average pressure over an entire breathing cycle. A number of current neonatal and adult ventilators are able to calculate the value. Paw is influenced by both the patient’s lung thoracic compliance (CLT) and airway resistance (RAW). If the ventilator settings are unchanged, a decrease in compliance or an increase in resistance will result in an increase in the mean airway pressure. This is because in a neonatal ventilator, the pressure limit is reached earlier and held for the duration of the inspiratory time. Conversely, if the patient’s compliance increases or the resistance decreases, the Paw will decrease. It is important to further evaluate the patient when a change in Paw is noticed. This is because the new pressure by itself does not show you whether there has been a change in compliance, resistance, or both. Any treatments that improve lung compliance and reduce airway resistance are shown by a reduced mean airway pressure.

In general, an increase in mean airway pressure increases the patient’s oxygenation. This is because the alveoli are kept open longer, allowing more time for diffusion and preventing alveolar collapse. If alveolar ventilation is improved, the PaCO2 will also be reduced. There is clinical evidence that a mean airway pressure of 12 or more cm water pressure is associated with an increased risk of pulmonary barotrauma and decreased cardiac output. This is especially true if PEEP is increased to raise the Paw. Watch the patient closely whenever a ventilator change is made that increases the Paw. A sudden deterioration in cardiopulmonary function may be caused by a pneumothorax. A reduction in urine output, an increased heart rate, and decreased blood pressure are often seen when the cardiac output is reduced. The mean airway pressure should be reduced if either of these situations is seen. To prevent these complications, it is necessary to reduce the mean airway pressure whenever the patient’s compliance improves.

Usually the mean airway pressure is the result of the patient’s lung compliance, airway resistance, and the various ventilator settings. The initial mean airway pressure should be considered along with the ventilator settings when interpreting the first set of arterial blood gases. Based on the blood gas results, ventilator adjustments may be needed. Note the Paw at each adjustment.

A number of ventilator control adjustments influence the patient’s mean airway pressure. (See Figure 16-11 for several examples of airway pressure tracings based on ventilator control changes.) If the patient’s compliance and resistance are stable, the Paw will be increased by the following: (1) an increased inspiratory flow, (2) an increased pressure limit (assuming the pressure limit has been previously reached), (3) an increase in PEEP, (4) an increased inspiratory time (assuming no change in ventilator rate and a decreased expiratory time), and (5) a decreased expiratory time (assuming an increased ventilator rate). These ventilator adjustments should result in an increased Pao2 and possibly a decreased PaCO2. Measure blood gases to be sure of the patient’s response.

If the patient’s compliance and resistance are stable, the Paw will be decreased by the following:

These ventilator adjustments may result in a decreased Pao2 and possibly an increased PaCO2. Measure blood gases to be sure of the patient’s response.

It should be noted that of all the various controls that have an influence on the mean airway pressure, PEEP has the greatest impact. There is usually a one-for-one relationship between the addition or removal of PEEP and the resulting Paw—. For example, the Paw—is 10 cm water when 5 cm water of PEEP is added. The resulting Paw—is seen to become 15 cm water. If 2 cm of PEEP is removed the Paw—will drop to 13 cm water.

7. Ventilator flow, volume, and pressure graphic waveforms

8. Prevent procedure-associated hypoxemia by oxygenating the patient before and after suctioning and equipment changes (ELE Code: IIID9) [Difficulty: ELE: R, Ap, An]

Chapter 13 discusses the suctioning procedure and steps that should be taken to prevent hypoxemia during suctioning. Older children can be given 100% oxygen during suctioning or equipment changes. Children younger than 6 months of age should have their oxygen percentage increased by 10% to 20% for the procedure.

MODULE C

1. Ventilators

As discussed in Chapter 15, the literature produced by the manufacturers and the descriptions used in many standard texts break the various ventilators into more categories than used by the NBRC. To avoid confusion, this text uses the NBRC’s more simplified terminology. A pneumatically powered ventilator is defined here as powered by compressed gas. It may be electrically controlled with electrical alarm systems. Fluidic ventilators are defined here as being pneumatically powered and partially or completely controlled by fluidic methods. Fluidic controls make use of compressed gas for cycling and other ventilator functions. Both of these types of neonatal ventilators use compressed air and oxygen that go to an air-oxygen mixer (blender) to determine the inspired oxygen. The gas then goes to a flow meter where the continuous flow per minute through the ventilator circuit is set. Depending on the ventilator, either compressed air or oxygen are used to drive the other control functions in fluidic ventilators.

An electrically powered ventilator is defined here as being electrically powered and controlled. Compressed air and oxygen go to a blender where the inspired oxygen is set. A microprocessor ventilator is defined here as being controlled by a microprocessor; it may be pneumatically or electrically powered. All of these types of ventilators are limited to the 150 breaths/min maximum rate set by the FDA. A high-frequency ventilator is capable of delivering a respiratory rate of more than 150/min. CPAP can be delivered through the types of ventilators described previously, manufactured CPAP-only units, or through a freestanding, assembled component system.

e. Manipulate high-frequency ventilators by order or protocol (WRE code: IIA6c) [Difficulty: WRE: R, Ap]

2. Manipulate ventilator breathing circuits by order or protocol (ELE code: IIA11c) [Difficulty: ELE: R, Ap, An]

a. Get the necessary equipment for the procedure

Conventional neonatal ventilators use a circuit that has all of the standard features of an adult circuit as discussed in Chapter 15. Commonly, disposable single-patient-use corrugated plastic circuits are used. They are inexpensive and meet the needs of most patients. Condensation is drained out into water traps that are placed at low points in the natural draping of the inspiratory and expiratory limbs of the circuit. If excessive moisture is a problem or if the gas temperature must be maintained within a narrow range, a heated-wire circuit may be used. These types of circuits are built with a heated wire either loosely threaded through the lumen or coiled within the tubing itself. They are integrated with the humidification system and a servo unit for automatic temperature regulation. Because of the added wiring, these disposable circuits are considerably more expensive than the simple circuits used with most patients. A heat-moisture exchanger (HME) is usually only used with children because the tidal volume must be greater than the dead space of the HME. If a HME is used for passive humidification, it is added between the patient’s endotracheal tube and the Y of the ventilator circuit.’

Be aware that corrugated circuits have a relatively high internal resistance and compressible volume. The corrugations lead to gas turbulence that increases as the flow is raised. When the tubing is warmed, it becomes more stretchable. This stretch results in more tidal volume lost to the circuit instead of being delivered to the patient.

When high flow rates and ventilating pressures are needed, as in HFV, a smooth bore and low compressible volume circuit is used instead of the standard disposable type. A special circuit made of noncompliant tubing is needed with the SensorMedics 3100A ventilator. In addition, to complete an HFJV circuit, a Hi-Lo Jet endotracheal tube or special endotracheal tube adapter is needed to deliver the jetted gas and add the entrained gas for the tidal volume. These are shown in Chapter 15.

3. Manipulate continuous positive airway pressure (CPAP) devices (Code: IIA2) [Difficulty: ELE: R, Ap; WRE: An]

5. Manipulate humidification equipment by order or protocol (ELE code: IIA3) [Difficulty: ELE: R, Ap, An]

a. Get the necessary equipment for the procedure

The general discussion of humidification equipment was presented in Chapters 8 and 15. See the figures there and the general discussion for set-ups in ventilator and CPAP breathing circuits. Both heated humidifiers and heat-moisture exchangers are used with pediatric patients. Heated passover-type humidifiers systems are preferred with neonates.

c. Troubleshoot any problems with the equipment

Again, see Chapters 8 and 15 for assembly and troubleshooting of humidification systems. With a Cascade-type of passover-type humidifier, the gas temperature is usually maintained close to the neonate’s body temperature to maintain a neutral thermal environment. Make sure that the water level is kept in the recommended range to properly humidify the gas.

MODULE D

1. Analyze the available information to determine the patient’s pathophysiologic state (Code: IIIH1) [Difficulty: ELE: R, Ap; WRE: An]

Refer to Chapter 1 or earlier in this chapter for a detailed discussion on neonatal assessment. A brief discussion of the most common neonatal pulmonary conditions requiring mechanical ventilation was presented earlier in this chapter.

2. Determine the appropriateness of the prescribed therapy and goals for the patient’s pathophysiologic state (Code: IIIH3) [Difficulty: ELE: R, Ap; WRE: An]

Specific recommendations for ventilatory support for the various pulmonary conditions were given earlier in the chapter.

3. Recommend the treatment of a pneumothorax (Code: IIIG1b) [Difficulty: ELE: R, Ap; WRE: An]

A chest radiograph and physical examination of the neonate will reveal if abnormal air or fluid is found around the lung(s) or heart. When transillumination of the chest is performed, any free air around the lung will be identified through the chest wall as a halo of light with a nonuniform shape. A nontension pneumothorax of greater than 10% is often also treated by inserting a pleural chest tube. If a patient has a tension pneumothorax, a pleural chest tube must be inserted to remove the air and relieve the pressure within the chest. A pleural chest tube is also placed to remove blood or other fluid from the pleural space. Chapter 18 has specific information that relates to treating a pneumothorax.

A pneumomediastinum, pneumopericardium, or pneumoperitoneum that puts the patient at risk must also be treated. A chest tube is then inserted into the area where the abnormal air is found. The same chest tube also removes any abnormal collection of fluid. A chest tube is usually placed behind the heart to remove any blood that should leak out after open-heart surgery.

If a neonate is being ventilated on a constant volume ventilator, the amount of air that is lost through the pleural chest tube can be calculated. This is done by subtracting the measured exhaled volume from the measured inhaled volume. For example:

image

It is not possible to measure tidal volume when the neonate is ventilated by any other means. In a case like this, it is only possible to make a qualitative judgment on pleural air leak. In other words, if air is seen to bubble out through the pleural drainage system, an air leak is present. When the air stops bubbling, the pleural tear has healed. See Chapter 18 for a complete discussion on pleural drainage systems.

4. Weaning from the ventilator

b. Initiate and modify weaning procedures (Code: IIID7 and IIIF2i12) [Difficulty: ELE: R, Ap; WRE: An]

Specific steps in increasing ventilator support were discussed earlier with each of the types of common pathologic conditions and the various modes of ventilation. In general, ventilator support should be reduced in the opposite manner that it was increased. Remember to evaluate the patient’s arterial blood gas values and vital signs before and after making a change in the ventilator parameters. If the patient’s condition deteriorates, the ventilator setting(s) should be placed as before. General steps in weaning ventilator support in a patient receiving traditional time-triggered, pressure-limited, time-cycled mechanical ventilation (TPTV) include the following:

BIBLIOGRAPHY

AARC Clinical Practice Guideline: application of continuous positive airway pressure to neonates via nasal prongs or nasopharyngeal tube. Respir Care. 1994;39:817.

AARC Clinical Practice Guideline: application of continuous positive airway pressure to neonates via nasal prongs, nasopharyngeal tube, or nasal mask—2004 revision and update. Respir Care. 2004;49(9):1100.

AARC Clinical Practice Guideline: care of the circuit and its relation to ventilator-associated pneumonia. Respir Care. 2003;48:869.

AARC Clinical Practice Guideline: evidence-based guidelines for weaning and discontinuing ventilatory support. Respir Care. 2002;47:69.

AARC Clinical Practice Guideline: humidification during mechanical ventilation. Respir Care. 1992;37:887.

AARC Clinical Practice Guideline: neonatal time-triggered, pressure-limited, time-cycled, mechanical ventilation. Respir Care. 1994;39:808.

AARC Clinical Practice Guideline: patient-ventilator system checks. Respir Care. 1992;37:882.

AARC Clinical Practice Guideline: removal of the endotracheal tube—2007 revision & update. Respir Care. 2007;52:81.

AARC Clinical Practice Guideline: surfactant replacement therapy. Respir Care. 1994;39:824.

AARC Clinical Practice Guideline: ventilator circuit changes. Respir Care. 1994;39:797.

Aloan CA, Hill TV. Respiratory care of the newborn and child, ed 2. Philadelphia: JB Lippincott-Raven, 1997.

Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatr. 1987;79:26.

Barnhart SL, Czervinske MP. Perinatal and pediatric respiratory care. Philadelphia: WB Saunders, 1995.

Betit P, Thompson J. Neonatal and pediatric respiratory care. In Wilkins RL, Stoller JK, Kacmarek RM, editors: Egan’s fundamentals of respiratory care, ed 9, St Louis: Mosby, 2009.

Boros SJ, Matalon SV, Ewald R, et al. The effect of independent variations in inspiratory-expiratory ratio and end expiratory pressure during mechanical ventilation in hyaline membrane disease: the significance of mean airway pressure. J Pediatr. 1977;91:794.

Branson RD, Hess DR, Chatburn RL. Respiratory care equipment, ed 2. Philadelphia: Lippincott Williams & Wilkins, 1999.

Burgess WR, Chernick V. Respiratory therapy in newborn infants and children, ed 2. New York: Thieme, 1986.

Cairo JM, Pilbeam SP. Mosby’s respiratory care equipment, ed 8. St Louis: Mosby, 2009.

Carlo WA, Martin RJ. Principles of neonatal assisted ventilation. Pediatr Clin North Am. 1986;33:221.

Cavanagh K. High frequency ventilation of infants: an analysis of the literature. Respir Care. 1990;35:815.

Chang DW. Clinical application of mechanical ventilation, ed 2. Albany, NY: Delmar, 2001.

Chatburn RL. High frequency ventilation: a report on a state of the art symposium. Respir Care. 1984;29:839.

Chatburn RL. Principles and practice of neonatal and pediatric mechanical ventilation. Respir Care. 1991;36:569.

Chatburn RL, Lough MD. Mechanical ventilation. In Lough MD, Doershuk CF, Stern RC, editors: Pediatric respiratory therapy, ed 3, St Louis: Mosby, 1985.

Chatburn RL, Waldemar AC, Lough MD. Clinical algorithm for pressure-limited ventilation of neonates with respiratory distress syndrome. Respir Care. 1983;28:1579.

Coghill CH, et al. Neonatal and pediatric high-frequency ventilation: principles and practice. Respir Care. 1991;36:596.

Gagnon C, Simoes J. The management of the mechanically ventilated infant receiving pancuronium bromide (Pavulon). Neonatal Network. Dec 1985:20-24.

Goldberg RN, Bancalari E. Bronchopulmonary dysplasia: clinical presentation and the role of mechanical ventilation. Respir Care. 1986;31:591.

Goldberg RN, Bancalari E. Therapeutic approaches to the infant with bronchopulmonary dysplasia. Respir Care. 1991;36:613.

Goldsmith JP, Karotkin EH. Assisted ventilation of the neonate, ed 2. Philadelphia: WB Saunders, 1996.

Hess DR, Kacmarek RM. Essentials of mechanical ventilation. New York: McGraw-Hill, 1996.

HIFI Study Group. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med. 1989;320:88.

Jobe A. Surfactant treatment for respiratory distress syndrome. Respir Care. 1986;31:467.

Koff PB, Eitzman DV, Neu J. Neonatal and pediatric respiratory care, ed 2. St Louis: Mosby, 1993.

MacIntyre NR, Branson RD. Mechanical ventilation, ed 2. Philadelphia: WB Saunders, 2009.

Milner AD, Hoskyns EW. High frequency positive pressure ventilation in neonates. Arch Dis Child. 1989;64:1.

Miyagawa CI. Sedation of the mechanically ventilated patient in the intensive care unit. Respir Care. 1987;32:792.

Nicks JJ, Becker MA. High-frequency ventilation of the newborn: past, present, and future. Respir Ther. 4(4), 1991.

Pilbeam SP, Cairo JM. Mechanical ventilation: physiological and clinical applications, ed 4. St Louis: Mosby, 2006.

Schmidt JM. Nitric oxide therapy in neonates: adding to the arsenal. Respir Ther. 1994;7:37.

Smith I. The impact of surfactant on neonatal intensive care unit management. Respir Ther. 1991;4(4):22-26.

Spear ML, Spitzer AR, Fox WW. Hyperventilation therapy for persistent pulmonary hypertension of the newborn. Neonatal Intensive Care: Perinatology/Neonatology. 1985;9:27.

Tobin MJ. What should the clinician do when a patient “fights the ventilator”? Respir Care. 1991;36:395.

Whitaker K. Comprehensive perinatal and pediatric respiratory care, ed 3. Albany, NY: Delmar, 2001.

White GC. Equipment theory for respiratory care, ed 4. Albany, NY: Delmar, 2005.

SELF-STUDY QUESTIONS FOR THE ENTRY LEVEL EXAM See page 601 for answers

STUDY QUESTIONS FOR THE WRITTEN REGISTRY EXAM See page 626 for answers

Share this: